Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | AZN | AMGN | GILD | VRTX |
| Company | Monte Rosa Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 17.34 | 90.62 | 317.89 | 122.25 | 445.65 |
| High | 17.75 | 91.52 | 320.19 | 123.74 | 448.33 |
| Low | 16.53 | 90.19 | 312.39 | 121.00 | 442.07 |
| Latest | 16.56 | 90.29 | 317.38 | 123.21 | 445.93 |
| Change | -0.67 | -1.22 | +2.00 | +1.87 | +1.29 |
| % Change | -3.89% | -1.33% | +0.63% | +1.54% | +0.29% |
| Volume | 632,800 | 6,628,200 | 2,455,100 | 4,892,200 | 1,178,300 |
| 20-Day Average Volume | 852,755 | 5,648,085 | 2,918,885 | 7,179,255 | 1,386,925 |
| Previous Close | 17.23 | 91.51 | 315.38 | 121.34 | 444.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.66 | 90.54 | 334.95 | 124.46 | 436.76 |
| 20-Day Raw Stochastic | 69.48% | 41.75% | 14.69% | 44.69% | 60.46% |
| 20-Day Relative Strength | 63.73 | 56.79 | 47.54 | 52.03 | 57.08 |
| Weighted Alpha | +173.46 | +38.80 | +17.36 | +31.89 | -0.26 |
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.06% since 12/04/25 | +0.29% since 12/04/25 | -6.70% since 12/04/25 | +0.48% since 12/04/25 | -2.50% since 12/04/25 |
| Low | 16.53 on 12/11/25 | 89.67 on 12/08/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 18.15 on 12/08/25 | 91.66 on 12/10/25 | 340.88 on 12/05/25 | 123.74 on 12/11/25 | 462.00 on 12/05/25 |
| 1-Month | |||||
| %Chg | +15.64% since 11/11/25 | +1.35% since 11/11/25 | -6.23% since 11/11/25 | +0.53% since 11/11/25 | +3.89% since 11/11/25 |
| Low | 12.94 on 11/18/25 | 87.23 on 11/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 18.15 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +238.65% since 09/11/25 | +11.33% since 09/11/25 | +12.26% since 09/11/25 | +4.54% since 09/11/25 | +12.22% since 09/11/25 |
| Low | 4.80 on 09/12/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 18.15 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +227.92% since 06/11/25 | +22.44% since 06/11/25 | +8.76% since 06/11/25 | +12.73% since 06/11/25 | -1.44% since 06/11/25 |
| Low | 4.12 on 08/08/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 18.15 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,078,354 | 280,027,776 | 170,903,104 | 152,864,192 | 113,140,912 |
| Shares Outstanding, K | 65,118 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 75,620,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -72,700,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 12,770,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -27,080,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.60 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/19/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 53.84 | 20.02 | 14.42 | 14.82 | 29.04 |